ArticleInternational journal of ophthalmology2025
Meibomian gland atrophy in children with allergic conjunctivitis.
Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of Meibomian Gland Loss Between Pediatric Patients with Blepharo-Keratoconjunctivitis and Age-Matched Controls Using Non-Contact Meibography.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate the factors influencing meibomian gland atrophy (MGA) in children with allergic conjunctivitis (AC).
methodsIn this cross-sectional study, 60 children with AC aged 6-17y and 20 age-matched children without signs or symptoms of ocular surface dysfunction were included. Information on the duration of AC, untreated time, electronic screen time (EST), outdoor exercise time, body mass index (BMI), and frequency of eye rubbing was collected using a health history form. The Standard Patient Evaluation of Eye Dryness (SPEED) score was used for dry eye assessment. Images of the meibomian glands (MGs) were obtained using Keratograph 5M, and the rate of meibomian gland atrophy (MGAR) was calculated using Image J. All subjects underwent routine eye examinations.
resultsThe average age of the AC group was 10.43±2.75y (range 6-17y) and 10.35±3.42y (range 6-14y) in the control group. The MGAR in the AC group was 33.42%±11.91%, significantly higher than that in the control group (18.10%±11.74%,
conclusionChildren with AC exhibit exacerbate MGA, with the degree of atrophy worsening as the untreated time of AC prolongs. Children under 12 years old show a higher MGAR, and EST non-projector negatively impacts MGA, while increased outdoor exercise time acts as a protective factor against MGA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.